We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+6.42%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.45B
AUM Growth
+$336M
Cap. Flow
+$603M
Cap. Flow %
41.48%
Top 10 Hldgs %
67.23%
Holding
768
New
375
Increased
70
Reduced
59
Closed
238

Top Buys

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$151M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$48.3M
3
ITOS
iTeos Therapeutics
ITOS
+$21.3M
4
QNGY
Quanergy Systems, Inc.
QNGY
+$11.5M
5
FULC icon
Fulcrum Therapeutics
FULC
+$10.9M

Top Sells

Rank Stock Value
1
SMH icon
VanEck Semiconductor ETF
SMH
+$30.8M
2
DIS icon
Walt Disney
DIS
+$23.1M
3
NGHC
National General Holdings Corp
NGHC
+$20.7M
4
STLA icon
Stellantis
STLA
+$19.7M
5
SVOKU
Seven Oaks Acquisition Corp. Unit
SVOKU
+$16M

Sector Composition

Rank Sector Weight
1 Healthcare 11.15%
2 Financials 9.75%
3 Technology 2.87%
4 Industrials 2.67%
5 Consumer Discretionary 1.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SOFI icon
526
CALL
SoFi Technologies
SOFI
$23.2B
$2K ﹤0.01%
+16,700
New +$330K
CHRS icon
527
CALL
Coherus Oncology
CHRS
$187M
$1K ﹤0.01%
+15,000
New +$255K
GT icon
528
CALL
Goodyear
GT
$1.75B
$1K ﹤0.01%
+16,800
New +$243K
VYX icon
529
PUT
NCR Voyix
VYX
$1.11B
$1K ﹤0.01%
+22,494
New +$495K
RDUS
530
PUT
DELISTED
Radius Health, Inc.
RDUS
$1K ﹤0.01%
10,000
+5,000
+100% +$105K
ABBV icon
531
CALL
AbbVie
ABBV
$442B
– –
-96,400
Closed -$1.04M
ALL icon
532
Allstate
ALL
$66.3B
– –
-7,129
Closed -$784K
AMC icon
533
CALL
AMC Entertainment Holdings
AMC
$2.14B
– –
-53,790
Closed -$165K
AMRN
534
CALL
Amarin Corp
AMRN
$296M
– –
-1,625
Closed -$10K
AMRN
535
Amarin Corp
AMRN
$296M
– –
-1,231
Closed -$120K
AMRN
536
PUT
Amarin Corp
AMRN
$296M
– –
-1,625
Closed -$13K
AQB icon
537
PUT
AquaBounty Technologies
AQB
$7.67M
– –
-500
Closed -$4K
BABA icon
538
Alibaba
BABA
$306B
– –
-16,171
Closed -$3.76M
BABA icon
539
PUT
Alibaba
BABA
$306B
– –
-16,900
Closed -$9K
BCRX icon
540
CALL
BioCryst Pharmaceuticals
BCRX
$2.64B
– –
-30,900
Closed -$55K
BHP icon
541
BHP
BHP
$229B
– –
-55,826
Closed -$3.25M
BIIB icon
542
CALL
Biogen
BIIB
$30.1B
– –
-10,400
Closed -$52K
BKSY icon
543
BlackSky Technology
BKSY
$1.22B
– –
-3,087
Closed -$259K
BLDP
544
PUT
Ballard Power Systems
BLDP
$784M
– –
-18,800
Closed -$3K
CB icon
545
Chubb
CB
$134B
– –
-9,993
Closed -$1.54M
CCC
546
CCC Intelligent Solutions
CCC
$4.05B
– –
-25,000
Closed -$332K
CELU icon
547
Celularity
CELU
$20.3M
– –
-2,500
Closed -$275K
CELUW
548
DELISTED
Celularity Inc
CELUW
– –
-379,789
Closed -$1.09M
CLF icon
549
CALL
Cleveland-Cliffs
CLF
$7.08B
– –
-218,200
Closed -$1.64M
CLF icon
550
Cleveland-Cliffs
CLF
$7.08B
– –
-71,912
Closed -$1.05M
20 21
22
23 24

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q1 2021 Portfolio in Review

As of Q1 2021, Cowen and Company held 768 positions worth $1.45B, up 30% from $1.12B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Cowen and Company deployed $603M of net new capital in Q1 2021, opening 375 new positions and adding to 70 existing holdings. Its largest new stake was iTeos Therapeutics: 588,238 shares worth $20.1M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 4.9% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Freeport-McMoran, an estimated $5.42M trimmed.

  • Cowen and Company's largest Q1 2021 buy was iTeos Therapeutics: 588,238 shares worth $20.1M.
  • Cowen and Company added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2021, an estimated $151M increase.
  • Cowen and Company's biggest Q1 2021 reduction was Freeport-McMoran, cutting an estimated $5.42M.
  • Cowen and Company fully exited VanEck Semiconductor ETF in Q1 2021, selling an estimated $30.8M.
  • Cowen and Company's ten largest holdings make up 67% of its $1.45B portfolio in Q1 2021.
  • Cowen and Company opened 375 new positions and closed 238 in Q1 2021.
  • Cowen and Company's portfolio value rose 30% quarter-over-quarter to $1.45B.

Based on Cowen and Company's 13F filing for Q1 2021, filed 4 May 2021.